Cargando…
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood with 5-year survival rate of 40% in high-risk patients despite intensive therapies. Recently, adoptive cell therapy, particularly chimeric antigen receptor (CAR) T cell therapy, represents a revolutionary treatment for hemat...
Autores principales: | Vanichapol, Thitinee, Chutipongtanate, Somchai, Anurathapan, Usanarat, Hongeng, Suradej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845499/ https://www.ncbi.nlm.nih.gov/pubmed/29682521 http://dx.doi.org/10.1155/2018/1812535 |
Ejemplares similares
-
Secretory High-Mobility Group Box 1 Protein Affects Regulatory T Cell Differentiation in Neuroblastoma Microenvironment In Vitro
por: Vanichapol, Thitinee, et al.
Publicado: (2018) -
Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
por: Sawaisorn, Piamsiri, et al.
Publicado: (2020) -
Cell-Main Spectra Profile Screening Technique in Simulation of Circulating Tumour Cells Using MALDI-TOF Mass Spectrometry
por: Chiangjong, Wararat, et al.
Publicado: (2021) -
Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal-regulated kinase signaling pathway
por: VANICHAPOL, THITINEE, et al.
Publicado: (2015) -
Genomics-Driven Precision Medicine in Pediatric Solid Tumors
por: Suthapot, Praewa, et al.
Publicado: (2023)